Skip to content

NOVOSIS clinical trial in patients with acute fracture of traumatic lower extremities

Researcher-led single-group, multi-organ, prospective, and therapeutic exploratory tests to evaluate the efficacy and safety of NOVOSIS in patients with acute fracture of traumatic upper and lower extremities

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0007514
Enrollment
90
Registered
2022-07-18
Start date
2022-08-01
Completion date
Unknown
Last updated
2022-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Koera University Guro Hospital
Lead Sponsor
Ajou University Hospital
Collaborator
Keimyung University Dongsan Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients over 19 years of age or with confirmed skeletal maturity (with radiologic evidence of epiphysal closure) 2) Patients requiring bone grafting due to acute fracture of traumatic lower extremities 3) Written consent to participation in this clinical study

Exclusion criteria

Exclusion criteria: 1) A person who does not agree to maintain contraception for one year after the procedure if he/she is pregnant, lactating, or a woman of childbearing age 2) Patients with malignancy or active malignancy 3) Patients with a history of cancer in the past and potential for metastasis (Nobosis is applicable if the disease has been cured and has not recurred in the past 5 years) 4) Patients with active infection at the surgical site 5) Patients with uncontrolled diabetes or hypertension or have blood clotting abnormalities 6) Hydroxyapatite, a person who has a history of overreaction to BMP-2 7) a patient with difficulty in follow-up 8) Patients with compartment syndrome of infected limb (limb) 9) For applications requiring strength 10) A person who does not use this product according to the following indications: - In case the internal/external fixation device cannot be used with the internal/external fixation rod and fracture joint plate during upper/lower fracture fusion - Patients with inadequate neurovascular conditions (e.g. high-risk amputations) during upper and lower limb fracture fusion - In the case of bone defect due to chronic fracture during upper and lower limb fracture fusion surgery

Design outcomes

Primary

MeasureTime frame
Percentage of bone fusion evaluated based on simple radiography (X-ray) results for 12 months after medical treatment

Secondary

MeasureTime frame
Bone fusion rate (%) evaluated based on simple radiography (X-ray) results for 6 months after medical treatment;Treatment success rate (%): Number of bone fusion subjects without additional intervention / total subjects x 100;Rate of occurrence of additional intervention (%): Describe the frequency with which additional intervention was performed to induce bone fusion.

Countries

Korea, Republic of

Contacts

Public Contactoh jongkeon

Koera University Guro Hospital

jongkeon.oh@gmail.com+82-2-2626-3088

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026